Perbak Capital Partners LLP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1968437 LONDON, X0

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$349,114

New position

Shares Held

6,754

first reported quarter

Ownership

0.012%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Perbak Capital Partners LLP holds $2,666,506 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	31,185	$1,102,701
2	UTHR	UNITED THERAPEUTICS Corp	1,438	$852,705
3	AMRX	Amneal Pharmaceuticals, Inc.	29,122	$361,986
4	SUPN	Supernus Pharmaceuticals, Inc. This page	6,754	$349,114

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$349,114	6,754	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.